Table 2 Characteristics and MTDH expression in breast cancer patients for tissue microarray study
From: MiR-128 suppresses metastatic capacity by targeting metadherin in breast cancer cells
| Factors | MTDH | |||
|---|---|---|---|---|
| Negative | Positive | Positive rate (%) | P value | |
| Type | 0.019c | |||
| Tumor | 15 | 22 | 59.46 | |
| Peritumoral | 26 | 11 | 29.73 | |
| Age(year) | 0.315c | |||
| < 40 | 5 | 11 | 68.75 | |
| ≥ 40 | 10 | 11 | 52.38 | |
| Grade | 1.000c | |||
| I | 1 | 1 | 50.00 | |
| II | 11 | 14 | 56.00 | |
| III | 2 | 4 | 66.67 | |
| Unknown | 1 | 3 | ||
| TNM stage | 0.627c | |||
| I/II/III | 13 | 17 | 56.67 | |
| IV | 1 | 4 | 80.00 | |
| Unknown | 1 | 1 | ||
| Node status | ||||
| Positive | 9 | 19 | 67.86 | 0.090c |
| Negative | 5 | 2 | 28.57 | |
| Unknown | 1 | 1 | ||
| Histopathological subtype | 1.000c | |||
| Ductal carcinoma | 14 | 19 | 57.58 | |
| Lobular carcinoma | 1 | 1 | 50.00 | |
| Others | 0 | 1 | 100.00 | |
| Unknown | 0 | 1 | ||